(Q38067439)

28 August 2017

1 reference

title

High-grade endometrial carcinomas - strategies for typing (English)

1 reference

28 August 2017

1

1 reference

28 August 2017

1 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

62

1 reference

28 August 2017

1

1 reference

28 August 2017

89-110

1 reference

Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.

28 August 2017

1 reference

Prognostic features of surgical stage I uterine carcinosarcoma

21 January 2018

1 reference

Management of recurrent endometrioid endometrial carcinoma: an overview

21 January 2018

1 reference

Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications.

21 January 2018

1 reference

Expression profiling of 22 genes involved in the PI3K-AKT pathway identifies two subgroups of high-grade endometrial carcinomas with different molecular alterations

21 January 2018

1 reference

Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.

21 January 2018

1 reference

Molecular characterization of uterine clear cell carcinoma

21 January 2018

1 reference

Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma

21 January 2018

1 reference

Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma

21 January 2018

1 reference

Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers

21 January 2018

1 reference

TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions

21 January 2018

1 reference

The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas.

21 January 2018

1 reference

Pathologic scoring of PTEN immunohistochemistry in endometrial carcinoma is highly reproducible

21 January 2018

1 reference

Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma

21 January 2018

1 reference

Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium

21 January 2018

1 reference

Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.

21 January 2018

1 reference

Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data

21 January 2018

1 reference

Immunophenotyping of serous carcinoma of the female genital tract

21 January 2018

1 reference

Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.

21 January 2018

1 reference

Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma

21 January 2018

1 reference

High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes

21 January 2018

1 reference

Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases

21 January 2018

1 reference

Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma

21 January 2018

1 reference

A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary

21 January 2018

1 reference

High-Grade Endometrial Carcinomas

21 January 2018

1 reference

p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes.

21 January 2018

1 reference

Undifferentiated carcinoma of the endometrium

21 January 2018

1 reference

Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?

21 January 2018

1 reference

Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems

21 January 2018

1 reference

A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis.

21 January 2018

1 reference

Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.

21 January 2018

1 reference

Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.

21 January 2018

1 reference

Two pathogenetic types of endometrial carcinoma

21 January 2018

1 reference

Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.

21 January 2018

1 reference

Immunohistochemical Evaluation of Estrogen and Progesterone Receptor Content in 183 Patients with Endometrial Carcinoma: Part I: Clinical and Histologic Correlations

21 January 2018

1 reference

Cyclin D1 expression in high-grade endometrial carcinomas--association with histologic subtype

21 January 2018

1 reference

Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry

21 January 2018

1 reference

Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma

21 January 2018

1 reference

Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset

21 January 2018

1 reference

Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients

21 January 2018

1 reference

Current and emerging trends in Lynch syndrome identification in women with endometrial cancer.

21 January 2018

1 reference

Lynch syndrome--related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types

21 January 2018

1 reference

Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome

21 January 2018

1 reference

WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium

21 January 2018

1 reference

Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray.

21 January 2018

1 reference

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.12029

1 reference

28 August 2017

1 reference

PubMed ID

23240672